Clinical Research at
Contemporary Dermatology

Over the past 20 years, Dr. Nossa has played a key role in the testing of numerous groundbreaking dermatological products upon their market introduction.

He has conducted extensive studies for various leading pharmaceutical companies, covering a broad spectrum of topics including psoriasis, atopic dermatitis, alopecia areata, hidradenitis suppurativa, acne, vitiligo, actinic keratosis, and warts.

Expanding the practice’s commitment to research, Contemporary Dermatology established a clinical research department in Marstons Mills, aimed at providing research opportunities to the local community. This initiative reflects the group’s dedication to advancing dermatological care and ensuring access to cutting-edge treatments for patients in the region.

Contemporary Dermatology is currently recruiting for the following studies:

CANDIN FOR THE TREATMENT OF COMMON WARTS
Sponsor: Nielson Biosciences

The goal of this clinical trial is to compare outcome in healthy subjects 12 years of age and older with at least 3, but no more than 20, common warts (Verruca vulgaris) following treatment with Candin or placebo. The main questions it aims to answer are:

  • Does treatment with Candin result in better clearance of warts than placebo

  • How many injections are required to result in wart clearance Participants will

  • Have one wart selected for injection every two weeks until clearance

  • Return 12 weeks after wart clearance for assessment of durability of response

For further details regarding ongoing clinical trials for which you may be eligible, please reach out to our dedicated research team. You can contact us by phone at 508-492-3200 or via email at Research@Contemporaryderm.com.